Exposure to more artificial light at night may raise heart disease risk
Reports and Proceedings
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 13-Dec-2025 19:12 ET (14-Dec-2025 00:12 GMT/UTC)
Higher levels of exposure to artificial light at night were linked to increased stress-related activity in the brain, inflamed arteries and a higher risk of heart disease, according to a small study of adults in Boston.
An artificial intelligence (AI) tool detected structural heart problems using a single-lead ECG captured by the electrical heart sensor on the back and digital crown of a smartwatch.
Adults with Type 2 diabetes (T2D) and at moderate or high risk of cardiovascular disease who took low-dose aspirin were less likely to experience a serious cardiovascular event, including a heart attack, stroke or death, than peers who did not take aspirin.
A review of 5 years of health records for more than 130,000 adults with insomnia who had used melatonin for at least a year found they were more likely to be diagnosed with heart failure, require hospitalization for the condition or die from any cause.
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.
A new PLOS ONE study from Lehigh University introduces a computational model that predicts how electrical stimulation affects atrial fibrillation. The framework could help optimize therapy strategies and move clinicians closer to personalized cardiac care.